Risk of second breast cancer events with chronic opioid use in breast cancer survivors.

Denise M BoudreauLu ChenOnchee YuErin J Aiello BowlesJessica Chubak

Published in: Pharmacoepidemiology and drug safety (2019)

This first US-based study on chronic opioid use and cancer outcomes provides some reassurance on safety. However, the question warrants further exploration in other populations and settings.

Keyphrases

papillary thyroid
squamous cell
type diabetes
squamous cell carcinoma
drug induced
metabolic syndrome
lymph node metastasis
insulin resistance